The New England Journal of Medicine found children with autism spectrum disorder did not show improvements in social or cognitive function after daily intranasal treatment with oxytocin for 24 weeks, compared with a control group. The placebo-controlled study included 290 children ages 3 to 17."/> The New England Journal of Medicine found children with autism spectrum disorder did not show improvements in social or cognitive function after daily intranasal treatment with oxytocin for 24 weeks, compared with a control group. The placebo-controlled study included 290 children ages 3 to 17."/> Oxytocin may not benefit children with ASD, study says

Oxytocin may not benefit children with ASD, study says

2021-10-15

A study published in The New England Journal of Medicine found children with autism spectrum disorder did not show improvements in social or cognitive function after daily intranasal treatment with oxytocin for 24 weeks, compared with a control group. The placebo-controlled study included 290 children ages 3 to 17.

Full story:

SNMMI SmartBrief

Nuclear medicine, molecular imaging and therapy

Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession.